This section presents information about the death rate statistics
for the various types of Blood conditions.
Disease | Death Rate Estimate | US deaths estimate | Statistic Used for Calculation |
| Blood conditions (overall) |
approx 1 in 31,146 or 0.00% or 8,732 people in USA |
8,732 |
|
| Anemia |
approx 1 in 77 or 1.29% or 3.5 million people in USA |
3.5 million (NHLBI) |
3.5 million (NHLBI)
|
| Iron deficiency anemia |
unavailable |
|
No information
|
| Sickle cell anemia |
approx 1 in 1,000 or 0.10% or 272,000 people in USA |
estimated 1 per 1,000 Hispanic Americans are affected by sickle cell disease in the US, Genetics Home Reference website |
estimated 1 per 1,000 Hispanic Americans are affected by sickle cell disease in the US, Genetics Home Reference website
|
| Cooley's anemia |
N/A |
N/A |
No information
|
| Aplastic anemia |
unavailable |
|
No information
|
| Clotting disorders |
N/A |
N/A |
No information
|
| Hemophilia |
approx 1 in 13,600 or 0.01% or 20,000 people in USA |
20,000 people in the United States (NHLBI) |
20,000 people in the United States (NHLBI)
|
| Porphyria |
N/A |
N/A |
No information
|
| Leukemia |
unavailable |
|
No information
|
| Purpura |
N/A |
N/A |
No information
|
| Viral Hemorragic Fevers |
N/A |
N/A |
No information
|
| Hemochromatosis |
approx 1 in 272 or 0.37% or 1 million people in USA |
more than 1 million Americans (CDC); 5 per 1000 in Caucasians (NIDDK); 1-in-200 to 1-in-300 |
more than 1 million Americans (CDC); 5 per 1000 in Caucasians (NIDDK); 1-in-200 to 1-in-300
|
| Amyloidosis |
N/A |
N/A |
less than 3,000 people in the US (Mayo Clinic)
|
| Autoimmune Hemolytic Anemia |
N/A |
N/A |
No information
|
| Autoimmune Hemophilia |
N/A |
N/A |
No information
|
| Autoimmune Lymphoproliferative Syndrome |
N/A |
N/A |
very rare; NIAID mentions 58 individuals
|
| Autoimmune Thrombocytopenia |
N/A |
N/A |
No information
|
| Bacteremia |
N/A |
N/A |
No information
|
| Balance disorders |
N/A |
N/A |
No information
|
| Bleeding disorders |
N/A |
N/A |
No information
|
| Circulatory disorder |
N/A |
N/A |
No information
|
| Classic Distal Renal Tubular Acidosis |
N/A |
N/A |
No information
|
| Dialysis-related amyloidosis |
N/A |
N/A |
No information
|
| Favism |
N/A |
N/A |
No information
|
| Hemolytic disease of the newborn |
N/A |
N/A |
No information
|
| Hemolytic uremic syndrome |
N/A |
N/A |
No information
|
| High Cholesterol |
N/A |
N/A |
estimated 101 million Americans have cholesterol >= 200 mg/dL (CDC)
|
| Hypercalcemia |
N/A |
N/A |
No information
|
| Hyperkalemia |
N/A |
N/A |
No information
|
| Hyperkalemic Renal Tubular Acidosis |
N/A |
N/A |
No information
|
| Hypoglycemia |
N/A |
N/A |
No information
|
| Hypokalemia |
N/A |
N/A |
No information
|
| Hypotension |
N/A |
N/A |
No information
|
| Immune Thrombocytopenic Purpura |
N/A |
N/A |
rare.
|
| Iron deficiency |
N/A |
N/A |
No information
|
| Jaundice |
N/A |
N/A |
No information
|
| Meningococcal disease |
unavailable |
|
No information
|
| Multiple Myeloma |
approx 1 in 4,317 or 0.02% or 63,000 people in USA |
about 63,000 people affected by multiple myeloma ("Orphan Products: Hope for People With Rare Diseases", By Carol Rados, FDA Consumer magazine, November-December 2003 Issue) |
about 63,000 people affected by multiple myeloma ("Orphan Products: Hope for People With Rare Diseases", By Carol Rados, FDA Consumer magazine, November-December 2003 Issue)
|
| Myeloma |
N/A |
N/A |
No information
|
| Pernicious anemia |
N/A |
N/A |
399,455 people in the USA 1996 1
|
| Primary amyloidosis |
N/A |
N/A |
No information
|
| Proximal Renal Tubular Acidosis |
N/A |
N/A |
No information
|
| Pulmonary hypertension |
N/A |
N/A |
No information
|
| Renal Tubular Acidosis |
N/A |
N/A |
No information
|
| Septicemia |
unavailable |
|
No information
|
| Sickle Cell Anemia |
approx 1 in 1,000 or 0.10% or 272,000 people in USA |
estimated 1 per 1,000 Hispanic Americans are affected by sickle cell disease in the US, Genetics Home Reference website |
estimated 1 per 1,000 Hispanic Americans are affected by sickle cell disease in the US, Genetics Home Reference website
|
| Thalassemia |
approx 1 in 272,000 or 0.00% or 1,000 people in USA |
1,000 people with Cooley's anemia (NHLBI) |
1,000 people with Cooley's anemia (NHLBI)
|
| Thrombocytopenia |
N/A |
N/A |
No information
|
| Thrombosis |
N/A |
N/A |
No information
|
| Von Willebrand disease |
N/A |
N/A |
estimated 3 million mostly undiagnosed
|
| Acidosis |
N/A |
N/A |
No information
|
| Alkalosis |
N/A |
N/A |
No information
|
| Hyperinsulinemia |
N/A |
N/A |
No information
|
| Hypertension |
approx 1 in 5 or 18.38% or 50 million people in USA |
50 million Americans (NHLBI); 217 per 1000 (NHIS95) |
50 million Americans (NHLBI); 217 per 1000 (NHIS95)
|
| Polycythemia |
N/A |
N/A |
No information
|
| Blood pressure disorders |
N/A |
N/A |
No information
|
| Eclampsia |
N/A |
N/A |
No information
|
| Orthostatic hypotension |
N/A |
N/A |
No information
|
| Preeclampsia |
N/A |
N/A |
No information
|
| Shock |
N/A |
N/A |
No information
|
| Methaemoglobinaemia |
N/A |
N/A |
No information
|
| Serious blood disorders |
N/A |
N/A |
No information
|
Rituxan is a monoclonal antibody therapy that was approved several years ago for specific types of non-Hodgkin's lymphoma . At the 2001 American...
In recent years, the drug Rituxan has become a well-established option only for certain forms of non-Hodgkin's lymphoma (NHL) There are other...
Chronic myeloid leukemia (CML) is a cancer of certain white blood cells. However, CML can also affect red blood cells and clotting cells called...
Doctors understand what goes wrong in CML more than they do in most other cancers. Learn what happens in the genes of white blood cells to cause CML.
See full list of 5 related videos
